Table 1.

Response to interferons and Apo2L of plasma cells isolated from the bone marrow of MM patients

Patient no.Age* (y)% of PCs at DxPrevious treatment% of PCs at selection% of PCs treatedApoptosis (%)
ControlαβγApo2L
66 80 CTX × 6 Clusters 90 8.7 15 15 ND 19 
77 100 RTX × 4 90 79 3.2 26 22 53  
69 80 RTX × 4 51 80 9.4 38 23 ND 31 
74 70 RTX × 4 80 81 3.2 24 13 ND 15 
46 80 No 80 100 5.2 31 27 31 
45 RMP, DVD × 8, CTX × 4 ND 90 5.2 25 21 14 85 
51 30 RTX × 4 20 90 6.3 36 34 17 86 
8B 44 60-70 VAD × 3 75 1.9 13 11  
   CTX × 2        
   DVD, RTX, De, DT        
8C     90 6.5 23 32 26 27 
9B 61 55 No 55 2.7 
9C     85 2.7 21 28 13 49 
10B 59 50 No 10-20 1.5 
10C     86 5.3 23 16 20 15 
5B1-153 46 80 RTX × 2 ND 26 3.6 ND 10 
5C1-153     92 6.7 ND 33 31 
Patient no.Age* (y)% of PCs at DxPrevious treatment% of PCs at selection% of PCs treatedApoptosis (%)
ControlαβγApo2L
66 80 CTX × 6 Clusters 90 8.7 15 15 ND 19 
77 100 RTX × 4 90 79 3.2 26 22 53  
69 80 RTX × 4 51 80 9.4 38 23 ND 31 
74 70 RTX × 4 80 81 3.2 24 13 ND 15 
46 80 No 80 100 5.2 31 27 31 
45 RMP, DVD × 8, CTX × 4 ND 90 5.2 25 21 14 85 
51 30 RTX × 4 20 90 6.3 36 34 17 86 
8B 44 60-70 VAD × 3 75 1.9 13 11  
   CTX × 2        
   DVD, RTX, De, DT        
8C     90 6.5 23 32 26 27 
9B 61 55 No 55 2.7 
9C     85 2.7 21 28 13 49 
10B 59 50 No 10-20 1.5 
10C     86 5.3 23 16 20 15 
5B1-153 46 80 RTX × 2 ND 26 3.6 ND 10 
5C1-153     92 6.7 ND 33 31 

PC, plasma cells; Dx, diagnosis; CTX, Cytoxan; ND, not detected; RTX, Rituxan; RMP, ritoxin + melphalan + prednisone; DVD, doxorubicin + vincristine + dexamethasone; B, C, nonplasma and plasma cells after CD138 selection; VAD, vincristine + adriamycin + doxorubicin; De, Decadron; DT, DTPASE.

PCs were isolated from the bone marrow of patients with MM by negative (patients 1-4) or positive selection. The plasma B cells (enriched more than 80%) were treated with IFN-α, β, or γ (2000 U/mL) or with Apo2L (400 ng/mL) for 48 hours. The apoptotic cells (> 200/sample) were then stained with Hoechst 33258, scored by fluorescence microscopy, and expressed as the percentage of the total cells.

*

Age at first diagnosis of multiple myeloma.

Identified from medical files and proved by pathologist.

Percentage of PCs in the samples treated with interferon (α, β, or γ) or with Apo2L.

F1-153

This patient was seen twice: at diagnosis and 2 months later.

Close Modal

or Create an Account

Close Modal
Close Modal